Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000353

Enrollment

Registered

1999-09-21

Start date

1996-10-31

Completion date

1997-10-31

Last updated

2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders, Substance-Related Disorders

Keywords

opiate dependence

Brief summary

The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.

Interventions

DRUGBuprenorphine/naloxone

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

19 Years to 57 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026